Market Focus Turns to Sandisk, Revolution Medicines, and McKesson Earnings
- August 02nd, 2026
- 117 views
LAS VEGAS, NV / CRWE PRESS RELEASE / August 2, 2026 - Among the companies set to release financial results on Wednesday, August 5, are:
Sandisk Corporation (Nasdaq: SNDK) is scheduled to release its fiscal fourth-quarter and full fiscal year 2026 financial results after the market closes. Wall Street analysts expect earnings of $34.51 per share on revenue of approximately $8.39 billion. $SNDK ended Friday's session at $1,214.83, declining $65.13, or 5.09%.
Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on targeted therapies for cancer, will report second-quarter 2026 results following the closing bell. Consensus estimates call for a loss of $2.06 per share on revenue of $15.47 million. $RVMD closed Friday at $187.53, down $4.64, or 2.41%.
McKesson Corporation (NYSE: MCK), one of the largest healthcare supply chain and pharmaceutical distribution companies in the United States, is set to announce first-quarter fiscal 2027 financial results after regular trading concludes. Analysts are forecasting earnings of $9.54 per share on revenue of $103.74 billion. $MCK finished Friday's session at $856.19, slipping $9.32, or 1.08%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026




Member Login